Literature DB >> 19948741

Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975.

C La Vecchia1, C Bosetti, F Lucchini, P Bertuccio, E Negri, P Boyle, F Levi.   

Abstract

BACKGROUND: To update the pattern of cancer mortality in Europe.
MATERIALS AND METHODS: We analysed cancer mortality in 34 European countries during 2000-2004, with an overview of trends in 1975-2004 using data from the World Health Organization.
RESULTS: From 1990-1994 to 2000-2004, overall cancer mortality in the European Union declined from 185.2 to 168.0/100 000 (world standard, -9%) in men and from 104.8 to 96.9 (-8%) in women, with larger falls in middle age. Total cancer mortality trends were favourable, though to a variable degree, in all major European countries, including Russia, but not in Romania. The major determinants of these favourable trends were the decline of lung (-16%) and other tobacco-related cancers in men, together with the persistent falls in gastric cancer, and the recent appreciable falls in colorectal cancer. In women, relevant contributions came from the persistent decline in cervical cancer and the recent falls in breast cancer mortality, particularly in northern and western Europe. Favourable trends were also observed for testicular cancer, Hodgkin lymphomas, leukaemias, and other neoplasms amenable to treatment, though the reductions were still appreciably smaller in eastern Europe.
CONCLUSION: This updated analysis of cancer mortality in Europe showed a persistent favourable trend over the last years.

Entities:  

Mesh:

Year:  2009        PMID: 19948741     DOI: 10.1093/annonc/mdp530

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  105 in total

1.  Recombinant human endostatin endostar inhibits tumor growth and metastasis in a mouse xenograft model of colon cancer.

Authors:  Yitao Jia; Min Liu; Wangang Huang; Zhenbao Wang; Yutong He; Jianhua Wu; Shuguang Ren; Yingchao Ju; Ruichao Geng; Zhongxin Li
Journal:  Pathol Oncol Res       Date:  2011-09-22       Impact factor: 3.201

Review 2.  Current concepts of organ preservation in head and neck cancer.

Authors:  C-J Wang; R Knecht
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-25       Impact factor: 2.503

3.  Nulliparity enhances the risk of second primary malignancy of the breast in a cohort of women treated for thyroid cancer.

Authors:  Fabrizio Consorti; Gianluca Di Tanna; Francesca Milazzo; Alfredo Antonaci
Journal:  World J Surg Oncol       Date:  2011-08-12       Impact factor: 2.754

4.  Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53-mutant breast cancers.

Authors:  Sara Rodriguez-Acebes; Ian Proctor; Marco Loddo; Alex Wollenschlaeger; Mohammed Rashid; Mary Falzon; A Toby Prevost; Richard Sainsbury; Kai Stoeber; Gareth H Williams
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

5.  Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer.

Authors:  R B Egerdie; F Saad; M R Smith; T L J Tammela; J Heracek; P Sieber; C Ke; B Leder; R Dansey; C Goessl
Journal:  Prostate Cancer Prostatic Dis       Date:  2012-09       Impact factor: 5.554

6.  [Laryngeal carcinoma: epidemiology, risk factors and survival].

Authors:  M Pantel; O Guntinas-Lichius
Journal:  HNO       Date:  2012-01       Impact factor: 1.284

7.  Characterization of Individuals Taking Part in Low Dose Computed Tomography (LDCT) Screening Program.

Authors:  Mariann Moizs; Gábor Bajzik; Zsuzsanna Lelovics; János Strausz; Marianna Rakvács; Péter Zádori; Árpád Kovács; Imre Repa
Journal:  Pathol Oncol Res       Date:  2015-05-25       Impact factor: 3.201

Review 8.  Multimodal treatment of gastric cancer in the west: Where are we going?

Authors:  Daniele Marrelli; Karol Polom; Giovanni de Manzoni; Paolo Morgagni; Gian Luca Baiocchi; Franco Roviello
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

9.  Long-term follow-up for cardiovascular disease after chemotherapy and/or radiotherapy for breast cancer in an unselected population.

Authors:  L M Boerman; A J Berendsen; P van der Meer; J H Maduro; M Y Berger; G H de Bock
Journal:  Support Care Cancer       Date:  2014-03-02       Impact factor: 3.603

10.  Analysis of geographical disparities in temporal trends of health outcomes using space-time joinpoint regression.

Authors:  Pierre Goovaerts
Journal:  Int J Appl Earth Obs Geoinf       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.